UNSPSC 51281667: Spectinomycin dihydrochloride pentahydrate

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HWT06H303Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears US NIH Compound Identifier 30971.

European Medicines Agency schedules Spectinomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12327MIG. Most nations, for tariff and trade purposes, schedule spectinomycin dihydrochloride pentahydrate under HS 29419000. SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.O.O.O.O.O.CL.CL.

UNSPSC 51281667 Spectinomycin dihydrochloride pentahydrate is a Commodity code that maps to pharmaceutical procurement activity, though recent state and local opportunities show minimal direct alignment with this specific antibiotic product. The opportunities tagged under this code predominantly involve broader medical and pharmaceutical supply purchases, emergency response medications, and generic multi-source pharmaceutical programs rather than spectinomycin-specific procurement. State and local buyers soliciting under this code include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue services (City of Tampa), and cooperative purchasing alliances serving multi-state jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance). The work spans naloxone and drug deactivation systems for community health support, first aid and emergency medical supplies for rescue operations, therapeutic pharmacy initiatives negotiating direct manufacturer relationships, and generic pharmaceutical and OTC product supply contracts distributed through authorized wholesalers.

Geographic activity clusters in Florida, Texas, and Minnesota, with the Minnesota MMCAP cooperative serving participating jurisdictions across additional states including Oregon. Recent representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023), the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 (due March 13, 2026, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount), and the Minnesota Department of Administration's RFP through MMCAP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026 and an effective contract date of July 1, 2026. The Texas HHS Commission also posted a Request for Information (RFI) on April 3, 2026 to explore direct-to-manufacturer prescription programs, indicating exploratory-phase procurement activity in the state pharmacy benefit space. The code shows limited recent direct solicitation for spectinomycin itself; opportunities are broader pharmaceutical and emergency medical supply categories.